An Asia-Pacific based, ICH-GCP compliant CRO offering a complete range of Clinical Research and New Drug Development Services.

Specialized in developing manufacturing processes for drugs and chemicals. Site also covers product and medical information, corporate overview, investor relations, and career center. (NYSE: ABT)

A broadly based emerging pharmaceutical company, with a balanced technology pipeline of novel low development risk product candidates and longer-term major product opportunities.

Develops novel metalloporphyrin therapeutics for the treatment of cancer and neurodegenerative diseases. Includes clinical trail for amyotrophic lateral sclerosis, investor details, and publications from Greenwood Village, Colorado.

Discovery, manufacture and marketing of products used in oncology and endocrine therapy, with development strategies and investor information. Quebec, Quebec, Canada. [French and English]

Drug discovery and development company with peptide drugs to treat cancer and immune-mediated diseases.

A player in the development of recombinant human lactoferrin (rhLF), is a biopharmaceutical company focused on developing protein-based drugs for oncology, asthma and wound healing.

Specializes in chemistry related to drug discovery and development.

Custom research organization specializing in synthesis of organic compounds, process and drug development and GMP manufacturing of pharmaceuticals and fine organic chemicals.

Development of pharmaceutical products for the complications of diabetes and age-related diseases.

Drug development company using the application of silicon medicinal chemistry for the development of innovative pharmaceuticals.

A private biopharmaceutical company focusing on DNA repair technology, dermatology, liposome diagnosis, skin cancer research and early cancer diagnosis and the lifestyle enhancement market.

AME's mission is to be the world leader in directed evolution, delivering superior value to patients, employees, collaborators and stockholders by discovering, developing and commercializing optimized human biotherapeutics.

Company which focuses on finding patenting and validating new uses for existing drugs.

Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series.

Drug discovery company focusing on pre-clinical anti-microbial candidates, including viral, bacterial and fungal diseases. Includes investor relations, strategic alliances, related news, technology overview, job opportunities and contacts in the borough.

A structure-based drug discovery company pioneering the use of High Throughput X-ray crystallography (HTX) for the rapid identification of novel drug candidates through structural screening-based in Cambridge, UK.

New Jersey biotechnology company is developing drug for the treatment of psoriasis, based on a leishmania protein extract.

A cutting edge, privately held company devoted to providing elegant and effective solutions to long standing human healthcare issues.

A highly productive, intensely focused, quality-oriented CRO; experienced, well established, and driven by scientific merit.

Provides contract research services to pharmaceutical and biotech companies, in the areas of chemistry, formulations, pre-clinical pharmabiology, and bioanalytical studies. Based in India.

Biological research firm doing pre-pharmaceutical research.

25 years in successfully developing, designing, producing, selling and marketing a complete line of diagnostics reagents and kits for use in hospitals, medical laboratories, research institutions and the health care and pharmaceutical industries.

A pharmaceutical company focusing on discovery and development of drugs for cancer and women's health.

Biota is an Australian listed company, based in Melbourne and engaged in the management of research and development of human pharmaceuticals for the treatment of viral respiratory diseases.

Specializes in pharmaceutical research, development and manufacturing of diabetes treatment drug DIAB II, also known as Sucanon, a new drug for the treatment of type 2 diabetes

Australian biomedical research company, which funds, manages, and commercialises diagnostic and therapeutic research projects including cancer diagnostic tests and antiviral agents.

Drug development company specialising in anti-infectives. Contains corporate information, product technology, vacancies and contact details.

Advanced evaluations, treatments, monitoring, education, for those with psychiatric and neurological diseases.

Develops, manufactures and markets vaccines and medications of biological origin. Includes career and investor information, and details of subsidiaries. Parkville, Victoria, Australia.

A product-focused cardiovascular drug development company based Vancouver.(Nasdaq: CRME)

Company focus on developing molecular therapies for congestive heart failure through the application of scientific discoveries in molecular cardiology.

Pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines for healthcare.

Russian research Center aimed at creation of original medicinal preparations for prevention and treatment of cardiovascular, nervous and mental diseases and viral, bacterial and fungus infections.

Pharmaceutical company that makes Remicade, a new treatment for Crohn's disease. Includes product and technology information and media resources.

The Leeds centre brings together more than 40 experts in biochemistry, chemistry, physics, biomedical science and clinical medicine to develop the new technology known as 'Photodynamics'.

Provides services in pharmacology, in molecular biology and lead development, in toxicology, metabolism and bio-availability, in combinatorial chemistry, HTS, HTP, HTLD and computational chemistry.

Drug research company, developing targeted medicines for the treatment of cancer, diabetes, obesity and depression based in Australia.

A leading provider of integrated drug discovery services to the Pharmaceutical and Biotechnology sectors.

Chembiotek, a research company set up at Salt Lake, Kolkata offers state-of-the-art, creative technology to pharmaceutical, chemical and biotechnology industries.

Studies, publications, and news about the diagnostic drugs, synthetic human and porcine secretin.

Contract drug discovery and development company, in Shenzhen, China.

Quebec-based pharmaceutical company. Research on chronic and neuropathic pain based on chloride ion imbalance in the spinal cord involving Kcc2.

A leading clinical research company, located in Leonia, New Jersey, U.S.A. We specialize in providing high quality and expedient early phase drug development services.

Drug design company focused on discovery and development of novel targeted medicines for the treatment of infectious diseases and cancer.

Developing innovative therapeutic and prophylactic products that harness the power of the immune system to treat cancer, allergy, asthma and infectious diseases, and help accelerate recovery of the immune system after cancer chemotherapies.

Discovering, developing and commercializing new therapeutic agents.

Development of proprietary, late stage pharmaceutical products that add market value and clinical benefit to existing drugs.

A company focused on the prediction and experimental evaluation of ADME and Pharmacokinetics for drug discovery.

Development stage pharmaceutical company focused on the identification of cytochrome P450 enzymes for development of drug candidates and diagnostics. Located in Kingston, Ontario, Canada.

Cytomyx provides its clients in the pharma-biotech and life-science communities with a complete range of genomic and proteomic discovery research services and reagents.

Privately-held Australian drug discovery company with a focus on inflammatory diseases such as: Asthma, Rheumatoid Arthritis, Allergic Rhinitis (Hay fever), Food allergy, Inflammatory Bowel Disease, inter alia. Cytopia's first molecular targets are members of the JAK family of protein tyrosine kinases.

Biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders.

Drug development company takes both the financial risk and business venture of the entire drug development.

Pharmaceutical company specialised in photodynamic therapy (PDT). Destiny has a custom research service specialised in formulations, in phospholipids, liposomes and other solubilisation and suspension systems.

Originators of clinical saliva testing for female and male hormones.

Manufacturing, marketing herbal products for psoriasis, vitiligo and other skin aliments.

EUCRO - aims to supply companies with new product opportunities through own product development or co-development, globalisation of licences and trading of health care products.

Guide to products and research for treatment of Alzheimers with Aricept.

Discovers and develops new small molecule drugs for treatment of inflammatory and central nervous system diseases. Includes company news, projects and profile of key management in Radebeul, Germany.

Eli Lilly Ireland, specialising in women's health, depression and schizophrenia.

A specialty pharmaceutical company principally engaged in the development of oral, controlled release products.

Canadian company providing products and services in the research and development of pharmaceuticals, including the sale of research quantities of specialty chemicals and brokering of scale-up and custom synthesis contracts.

A subsidiary of Bertin Group in the healthcare and life science division providing innovation and services in pharmaceutical development.

Medical, pharmaceutical diagnostic projects using state-of-the-art pharmadiagnostic technologies.

Veterinary pharmaceutical research and development firm dedicated to solutions for fescue toxicosis and other animal problems, especially for equine.

Genomics, proteomics and biologics. Focuses on the high resolution separation and identification of proteins from human tissue and analysis to describe differences between diseased and normal states for rapid drug discovery. Liège.

Characterizing and developing conventional and novel drug delivery systems. Describes staff, research projects, courses offered, and publications. Located in Jena, Germany.

Research into Optimised Human Health through Natural Nutriture, with minimal use of dietary supplements and natural medicines, if at all. Eradication of AIDS, Parasites, Cancer, Cardiovascular Disease, and premature aging.

Genentech's mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or improve lives every day.

A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.

Product development and contract research organization for the North American pharmaceutical industry.

Provider of plasma-based products in the fields of regenerative medicine, oncology, and auto-immune diseases.

Provides research, development, testing, quality assurance, contract manufacturing and expert witness services to the pharmaceutical industries.

RxIBR is bringing innovations, Targeted Biologic Therapy from the Institute of Biologic Research into commercial fruition.

Jordan based pharmaceutical research center, offer services including clinical service, bioanalysis service, data management, quality assurance.

Developing platform electroporation technology for targeted in vivo delivery of membrane limited therapeutic agents including pharmaceutical compounds and DNA-based therapies.

Research company and institute dedicated to the discovery of novel drugs and therapeutics for diabetes, its complications, obesity, and related disorders.

The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease.

Develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders.

Biomedical pharmaceutical company working on new treatments for Crohn's Disease.

Company in genetic discovery producing drug targets and DNA chips.

A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.

Drug discovery and development company that is focused on next generation anti-cancer drugs.

Provides development and support services to pharmaceutical firms and contract research organizations.

A discovery company combining scientific investigation of traditional plant-based remedies and latest scientific technology to offer novel bioactive molecules to the pharmaceutical, cosmeceutical, nutraceutical and biotechnology industries.

Provider of chemical structural databases and information management software to the chemical, agrochemical, and pharmaceutical industry.

A global contract research organization, offering a complete spectrum of services in drug discovery and development.

Developing treatments for CNS disease.

Development and licencing out of novel presentations of off-patent generic pharmaceuticals and medical devices. Specialising in the fields of urology, intravenous fluids, woundcare and anaesthesia in plastic and flexible delivery systems.

Services in support of Erythromycin Breath Test and mass spectrometry service for measuring stable isotopes.

Develops and markets innovative products to guide and improve treatment of viral diseases. (Nasdaq: MGRM).

Leader in the biopharmaceutical drug delivery field, with technology of apply its polymer coupling technology platforms and advanced analytical methods.

Specializes in combining inhibitors of bacterial resistance with proven antibiotics to treat serious infections. Based in San Diego, California.

Biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies. Services include drug discovery, gene discovery and genetic testing.

Dr Reddy's custom pharmaceutical services provides medicinal chemistry, process research and development and CGMP scale-up, formulation development and CGMP scale-up for clinical trials.

Research, diagnostics and pharmaceutical development related to nanobacterial infectious disease.

A company focuses on developing nano-scale inhaled, nasal, injectable, and oral delivery systems for improved drug therapies base Alachua, Florida

Researches and develops compounds that inhibit the formation, deposition and toxic effects of amyloid fibrils within the body.

Neurotech Pharmaceuticals, founded in Apr.1998, aims to develop and invent Novel lead compounds that will threaten diseases associated with brain disorders and mal-functional retardances.

A global leader in research, development and manufacturing of innovative ophthalmic pharmaceuticals that assist in the treatment diseases and disorders of the eye.

An independent biopharmaceutical company engaged in the discovery and development of pharmaceuticals for the treatment of life threatening human viral diseases.

Antibiotic discovery, using proprietary technology as a platform, for growing previously unculturable microorganisms in the laboratory. Includes publications, related news, and careers in Cambridge, Massachusetts.

Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and history of company, with offices in Europe and North America, and headquarters in North Ryde, New South Wales. (Nasdaq: NVGN)

Development of techniques to focus the release of cytostatics to tumour tissue based in Uppsala, Sweden.

Develops an anti-obesity drug aimed at treating general obesity, preventing weight gain associated with anti-psychotic drug therapy, and improving lipid profiles.

Developer of Microcyn 60 disinfectant, L3 oncology compound and drug-eluting stents along with other disruptive health care technologies.

Involved in research, development and production of new antileukemic drugs.

A research-oriented biotechnology company gaining new insights into ORIgins of DISeases with genomic and proteomic investigation of human diseased tissues. The company will develop new diagnostic and therapeutic targets and substances.

Biopharmaceutical company focused on the discovery and development of pharmaceutical and diagnostics products.

Pharmaceutical manufacturing and research company committed to providing manufacturing and scientific services to the health-care industry that meet and exceed our customer's expectation of quality, while always striving for continuous improvement.

Pharmaceutical company developing novel antimalarial drugs candidates against resistant strains of Plasmodium falciparum.

A contract research organization providing products and research services in molecular biology, cell culture, biochemistry, and molecular histology to accelerate each client's drug discovery and preclinical development efforts.

A full service contract research organization, a member of AALAS following AAALAC and NIH guidelines. We can supply all the services you need for drug development; from in vitro screening through preclinical animal studies to low cost preliminary clinical trials coordinated and performed offshore.

Site contains overview of new anti-infective technology developed by the company and problems of drug resistance in general. Bacterial Transforming Agents change antibiotic-resistant bacteria, e.g. MRSA, into antibiotic-susceptible bacteria.

Core business is formulation development together with clinical trial material manufacturing and commercial manufacture of low volume products.

Offers an investor center, patent information, company overview, job opportunities, and contact details.

Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system disorders.

Company focus on the research and development of novel pharmaceutical and functional food products based on clinical and pre-clinical data generated from medicinal plant extracts.

Research and development and production of new porphyrinic photosensitizers for photodynamic cancer therapy and other applications in collaboration with partners from institutes and universities throughout Europe.

A division of the Department of Pharmceutics at Rutgers University which conducts preclinical studies in absorption, metabolism, distribution, and excretion (ADME) assessment of new chemical entities and of existing drug compounds incorporated into drug delivery vehicles.

Compounding and research pharmacy with a focus in drug delivery systems, primarily in the topical therapeutic application of drugs. PDL has developed several new compounds for the management of pain and nausea, especially for the terminally ill hospice patient.

Our mission is to discover, develop, and make available new treatments that meet unmet medical needs for people suffering from central nervous system (CNS) disorders.

Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals and humans against lethal gastrointestinal pathogens and carcinogens.

A medium sized research and development company located Freiburg southwest of Germany focusing on protein kinase targeted drug discovery.

Developing therapies for neurological disorders such as spinal cord injuries, neurodegenerative diseases and glaucoma. Features explanation of technology and details of clinical studies. Los Angeles, California, USA.

Research and development biotechnology company specializing in treatments for type 2 diabetes and obesity.

A biotechnology company dedicated to the discovery and development of diabetes mellitus treatment. Information on diabetes, type 2 diabetes, diabetes mellitus

Pharmaceutical company engaged in the discovery, development, and commercialization of leading-edge technology in the areas of oncology and dermatology.

Global company aiming to maximize developments and discoveries of academic research into breakthrough treatments for human disease.

Biopharmaceutical company located in Atlanta, Georgia. It is a subsidiary of Dr. Reddy's Group, Hyderabad, India. Our research focus is on discovering novel therapeutics that address unmet medical needs in diabetes, inflammation, lipid metabolism, oncology and cardiovascular disease.

Pharmaceutical research and development company focused on developing drugs to treat diabetes, obesity and CNS disorders.

Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and analysis of proteins for human therapeutic or diagnostic use according to international standards.

[Padova] Fa ricerca nel campo dell'oncologia e della neurologia e offre prodotti e servizi a industrie farmaceutiche, biotecnologiche e strutture del settore sanitario. Presenta l'azienda e l'attività.

Development and distribution of products for the treatment of major diseases, with company profile and research details. Milan, Italy.

Early stage pharmaceutical company specializing in targeted delivery of therapeutic compounds to specific immune cells as cost-effective therapy for inflammatory and autoimmune diseases.

A biopharmaceutical company discovering and developing new drugs to fight cancer.

Biopharmaceutical company focused on saving lives utilizing Samaritan Laboratories, Georgetown University's School of Medicine, to identify and design drugs for Alzheimer's, AIDS, cancer and cholesterol and process resulting "drug candidates" through the FDA to obtain approval.

Sapient Discovery - leading service provider of structure based drug design encompassing advanced bioinformatics, computational and X-ray crystallography.

Develops and commercializes potentially improved versions of widely-prescribed drugs, designed to offer meaningful improvements in patient outcome through reduced side effects, increased efficacy, or improved dosage forms. (Nasdaq: SEPR).

Commercial contract research organization (CRO) providing low cost pre-clinical drug development services to biopharmaceutical companies (pharmicological screening and acute toxicology).

A South African biopharmaceutical discovery company that innovates therapeutic compounds in proprietary drug delivery systems, with cancer research as a primary focus.

Global specialty pharmaceutical company focusing on central nervous system (CNS), gastrointestinal (GI), and renal diseases. Based in Chineham, England. (Nasdaq: SHPGY)

Develop treatments based on RNAi technology for asthma, diabetes, hepatitis C, macular degeneration and Huntington's Disease. Includes product pipeline, overview of company with research and manufacturing in Boulder, Colorado, headquartered in San Francisco, California.

Speedel's business objective is to acquire/in-license and develop innovative molecules through fast-track drug development and innovative technical problem solving in the drug development process.

Details all research areas and areas of expertise.

Specializes in the drug discovering using GPCR targets and development focusing on oncology and anti-inflammatory drug discovery and development

Our mission is to optimize the therapy and prevention of disease in populations in the US and abroad through regulatory support, innovative epidemiological research, education, and product development.

A company focused on discovery and development of biotherapeutics for treatment of vascular diseases.

An international pharmaceutical company, accelerating discovery and development of breakthrough drugs in HIV/AIDS and other therapeutic diseases.

Pharmaceutical company engaged in research and development in the fields of allergic/respiratory diseases and disorders of the central nervous system.

Development and marketing of medications used in the fields of neurology, dermatology and infectious diseases. Includes corporate and production details. Headquarters in Aliso Viejo, California, USA.

A biotechnical company engaged in research and commercial development of immune modulation therapies for the treatment of cardiovascular, neurological, and other chronic inflammatory diseases.

Biopharmaceutical research and development company with a pipeline including treatments for migraine, obesity, sexual disfunction and Parkinson's disease.

Developing cause-oriented treatment for Parkinson's, Alzheimer's, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event in these neurodegenerative disorders, with proprietary polyamine drug, Tetramine.

Isolating and identifying hibernation-related peptides that can become therapies for stroke, heart disease, high blood pressure, obesity, cancerous tumors, kidney failure and other human diseases.

Researches and develops therapeutic products for the treatment of Cancer and Cancer related disorders. (Nasdaq: VION).

The new Benaroya Research Institute at Virginia Mason is a state-of-the-art facility built specifically for collaborative biomedical research.

Virinova has developed a novel virus diagnostic technology for process control and diagnostic monitoring of viral infections. No antibodies or PCR is required and the method is suitable for all virus types including unknown viruses. It allows the direct detection of virus particles in minutes.

Nanotechnology research and development of antibiotic, antitumor and custom peptides.

A research and development company offering analytical, preformulation, formulation and stability testing services to the pharmaceutical and biotechnology industries.

Research-based, global pharmaceutical company responsible for the discovery and development of medicines.

A fully integrated Pharmaceutical and Nutraceutical Company, providing generic and proprietary drugs for tomorrow's market place.

A generic pharmaceutical research and development company.

An independent CRO devoted to develop and implement innovative preclinical tests for drug discovery and safety pharmacology. Cardiovascular system (safety pharmacology : HERG and action potential